599 related articles for article (PubMed ID: 34166617)
1. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.
Meng B; Kemp SA; Papa G; Datir R; Ferreira IATM; Marelli S; Harvey WT; Lytras S; Mohamed A; Gallo G; Thakur N; Collier DA; Mlcochova P; ; Duncan LM; Carabelli AM; Kenyon JC; Lever AM; De Marco A; Saliba C; Culap K; Cameroni E; Matheson NJ; Piccoli L; Corti D; James LC; Robertson DL; Bailey D; Gupta RK
Cell Rep; 2021 Jun; 35(13):109292. PubMed ID: 34166617
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 evolution during treatment of chronic infection.
Kemp SA; Collier DA; Datir RP; Ferreira IATM; Gayed S; Jahun A; Hosmillo M; Rees-Spear C; Mlcochova P; Lumb IU; Roberts DJ; Chandra A; Temperton N; ; ; Sharrocks K; Blane E; Modis Y; Leigh KE; Briggs JAG; van Gils MJ; Smith KGC; Bradley JR; Smith C; Doffinger R; Ceron-Gutierrez L; Barcenas-Morales G; Pollock DD; Goldstein RA; Smielewska A; Skittrall JP; Gouliouris T; Goodfellow IG; Gkrania-Klotsas E; Illingworth CJR; McCoy LE; Gupta RK
Nature; 2021 Apr; 592(7853):277-282. PubMed ID: 33545711
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion.
Ferreira IATM; Kemp SA; Datir R; Saito A; Meng B; Rakshit P; Takaori-Kondo A; Kosugi Y; Uriu K; Kimura I; Shirakawa K; Abdullahi A; Agarwal A; Ozono S; Tokunaga K; Sato K; Gupta RK; ;
J Infect Dis; 2021 Sep; 224(6):989-994. PubMed ID: 34260717
[TBL] [Abstract][Full Text] [Related]
4. The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus.
Kim YJ; Jang US; Soh SM; Lee JY; Lee HR
Viruses; 2021 Apr; 13(4):. PubMed ID: 33917138
[TBL] [Abstract][Full Text] [Related]
5. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.
Wang P; Nair MS; Liu L; Iketani S; Luo Y; Guo Y; Wang M; Yu J; Zhang B; Kwong PD; Graham BS; Mascola JR; Chang JY; Yin MT; Sobieszczyk M; Kyratsous CA; Shapiro L; Sheng Z; Huang Y; Ho DD
Nature; 2021 May; 593(7857):130-135. PubMed ID: 33684923
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.
Andreano E; Piccini G; Licastro D; Casalino L; Johnson NV; Paciello I; Dal Monego S; Pantano E; Manganaro N; Manenti A; Manna R; Casa E; Hyseni I; Benincasa L; Montomoli E; Amaro RE; McLellan JS; Rappuoli R
Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34417349
[TBL] [Abstract][Full Text] [Related]
7. Mutational Hotspot in the SARS-CoV-2 Spike Protein N-Terminal Domain Conferring Immune Escape Potential.
Kubik S; Arrigo N; Bonet J; Xu Z
Viruses; 2021 Oct; 13(11):. PubMed ID: 34834921
[TBL] [Abstract][Full Text] [Related]
8. Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies.
Alenquer M; Ferreira F; Lousa D; Valério M; Medina-Lopes M; Bergman ML; Gonçalves J; Demengeot J; Leite RB; Lilue J; Ning Z; Penha-Gonçalves C; Soares H; Soares CM; Amorim MJ
PLoS Pathog; 2021 Aug; 17(8):e1009772. PubMed ID: 34352039
[TBL] [Abstract][Full Text] [Related]
9. A SARS-CoV-2 mutant from B.1.258 lineage with ∆H69/∆V70 deletion in the Spike protein circulating in Central Europe in the fall 2020.
Brejová B; Boršová K; Hodorová V; Čabanová V; Reizigová L; Paul ED; Čekan P; Klempa B; Nosek J; Vinař T
Virus Genes; 2021 Dec; 57(6):556-560. PubMed ID: 34448987
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 Serum Drives Spike-Mediated SARS-CoV-2 Variation.
Yu Y; Zhang M; Huang L; Chen Y; Wu X; Li T; Li Y; Wang Y; Huang W
Viruses; 2024 May; 16(5):. PubMed ID: 38793644
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.
Motozono C; Toyoda M; Zahradnik J; Saito A; Nasser H; Tan TS; Ngare I; Kimura I; Uriu K; Kosugi Y; Yue Y; Shimizu R; Ito J; Torii S; Yonekawa A; Shimono N; Nagasaki Y; Minami R; Toya T; Sekiya N; Fukuhara T; Matsuura Y; Schreiber G; ; Ikeda T; Nakagawa S; Ueno T; Sato K
Cell Host Microbe; 2021 Jul; 29(7):1124-1136.e11. PubMed ID: 34171266
[TBL] [Abstract][Full Text] [Related]
12. Recent progress on the mutations of SARS-CoV-2 spike protein and suggestions for prevention and controlling of the pandemic.
Li X; Zhang L; Chen S; Ji W; Li C; Ren L
Infect Genet Evol; 2021 Sep; 93():104971. PubMed ID: 34146731
[TBL] [Abstract][Full Text] [Related]
13. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.
Thomson EC; Rosen LE; Shepherd JG; Spreafico R; da Silva Filipe A; Wojcechowskyj JA; Davis C; Piccoli L; Pascall DJ; Dillen J; Lytras S; Czudnochowski N; Shah R; Meury M; Jesudason N; De Marco A; Li K; Bassi J; O'Toole A; Pinto D; Colquhoun RM; Culap K; Jackson B; Zatta F; Rambaut A; Jaconi S; Sreenu VB; Nix J; Zhang I; Jarrett RF; Glass WG; Beltramello M; Nomikou K; Pizzuto M; Tong L; Cameroni E; Croll TI; Johnson N; Di Iulio J; Wickenhagen A; Ceschi A; Harbison AM; Mair D; Ferrari P; Smollett K; Sallusto F; Carmichael S; Garzoni C; Nichols J; Galli M; Hughes J; Riva A; Ho A; Schiuma M; Semple MG; Openshaw PJM; Fadda E; Baillie JK; Chodera JD; ; ; Rihn SJ; Lycett SJ; Virgin HW; Telenti A; Corti D; Robertson DL; Snell G
Cell; 2021 Mar; 184(5):1171-1187.e20. PubMed ID: 33621484
[TBL] [Abstract][Full Text] [Related]
14. High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape.
Schmidt F; Weisblum Y; Rutkowska M; Poston D; DaSilva J; Zhang F; Bednarski E; Cho A; Schaefer-Babajew DJ; Gaebler C; Caskey M; Nussenzweig MC; Hatziioannou T; Bieniasz PD
Nature; 2021 Dec; 600(7889):512-516. PubMed ID: 34544114
[TBL] [Abstract][Full Text] [Related]
15. Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion.
Salleh MZ; Derrick JP; Deris ZZ
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299045
[TBL] [Abstract][Full Text] [Related]
16. Antibody evasion by the P.1 strain of SARS-CoV-2.
Dejnirattisai W; Zhou D; Supasa P; Liu C; Mentzer AJ; Ginn HM; Zhao Y; Duyvesteyn HME; Tuekprakhon A; Nutalai R; Wang B; López-Camacho C; Slon-Campos J; Walter TS; Skelly D; Costa Clemens SA; Naveca FG; Nascimento V; Nascimento F; Fernandes da Costa C; Resende PC; Pauvolid-Correa A; Siqueira MM; Dold C; Levin R; Dong T; Pollard AJ; Knight JC; Crook D; Lambe T; Clutterbuck E; Bibi S; Flaxman A; Bittaye M; Belij-Rammerstorfer S; Gilbert SC; Carroll MW; Klenerman P; Barnes E; Dunachie SJ; Paterson NG; Williams MA; Hall DR; Hulswit RJG; Bowden TA; Fry EE; Mongkolsapaya J; Ren J; Stuart DI; Screaton GR
Cell; 2021 May; 184(11):2939-2954.e9. PubMed ID: 33852911
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization.
Hoffmann M; Zhang L; Krüger N; Graichen L; Kleine-Weber H; Hofmann-Winkler H; Kempf A; Nessler S; Riggert J; Winkler MS; Schulz S; Jäck HM; Pöhlmann S
Cell Rep; 2021 Apr; 35(3):109017. PubMed ID: 33857422
[TBL] [Abstract][Full Text] [Related]
18. An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies.
Liu Y; Soh WT; Kishikawa JI; Hirose M; Nakayama EE; Li S; Sasai M; Suzuki T; Tada A; Arakawa A; Matsuoka S; Akamatsu K; Matsuda M; Ono C; Torii S; Kishida K; Jin H; Nakai W; Arase N; Nakagawa A; Matsumoto M; Nakazaki Y; Shindo Y; Kohyama M; Tomii K; Ohmura K; Ohshima S; Okamoto T; Yamamoto M; Nakagami H; Matsuura Y; Nakagawa A; Kato T; Okada M; Standley DM; Shioda T; Arase H
Cell; 2021 Jun; 184(13):3452-3466.e18. PubMed ID: 34139176
[TBL] [Abstract][Full Text] [Related]
19. The great escape? SARS-CoV-2 variants evading neutralizing responses.
Prévost J; Finzi A
Cell Host Microbe; 2021 Mar; 29(3):322-324. PubMed ID: 33705702
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants.
Yi C; Sun X; Lin Y; Gu C; Ding L; Lu X; Yang Z; Zhang Y; Ma L; Gu W; Qu A; Zhou X; Li X; Xu J; Ling Z; Xie Y; Lu H; Sun B
Genome Med; 2021 Oct; 13(1):164. PubMed ID: 34649620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
